Elite Pharmaceuticals, Inc.
ELTP · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4 | $20 | $4 | $9 |
| Dep. & Amort. | $2 | $1 | $1 | $1 |
| Deferred Tax | $4 | -$20 | $1,510 | -$2 |
| Stock-Based Comp. | $0 | $9 | $1 | $1 |
| Change in WC | -$15 | -$12 | -$2 | -$1 |
| Other Non-Cash | $21 | -$2 | -$1,510 | -$1 |
| Operating Cash Flow | $7 | -$3 | $3 | $7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$1 | -$6 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$1 | $0 | $0 | $0 |
| Investing Cash Flow | -$2 | -$1 | -$6 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | $3 | $2 | -$1 |
| Stock Issued | $0 | $160 | $39 | $14 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$1 | $3 | $2 | -$1 |
| Forex Effect | $0 | $0 | -$695 | $0 |
| Net Chg. in Cash | $4 | -$1 | -$1 | $5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8 | $8 | $9 | $4 |
| End Cash | $12 | $8 | $8 | $9 |
| Free Cash Flow | $5 | -$4 | -$2 | $6 |